-
OSI Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. DC CAFC
- 1:09-cv-00185
- D. Del.
- Judge: Sue L. Robinson
- Filed: 03/19/2009
- Closed: 05/01/2012
- Latest Docket Entry: 04/17/2014
- PACER
- Docket updated daily
3
Plaintiffs
2
Defendants
1
Accused
Product
3
Patents-in-Suit
1,140
Days in
Litigation
-
OSI Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. DC CAFC
- 1:09-cv-00185
- D. Del.
- Judge: Sue L. Robinson
- Filed: 03/19/2009
- Closed: 05/01/2012
- Latest Docket Entry: 04/17/2014
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Mylan Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic TarcevaRlotinib hydrochloride tablets 100 mgRlotinib hydrochloride tablets 150 mgRlotinib hydrochloride tablets 25 mg | US 6,900,221 B1 |
53
|
Infringement
Entry 244Entry 250 |
| Generic TarcevaRlotinib hydrochloride tablets 100 mgRlotinib hydrochloride tablets 150 mgRlotinib hydrochloride tablets 25 mg | US RE41,065 E1 |
1, 2, 4, 8, 34, 35
|
Infringement
Entry 244Entry 250 |
